(0.25%) 5 144.25 points
(0.20%) 38 518 points
(0.36%) 17 910 points
(-0.39%) $83.52
(1.98%) $1.961
(0.09%) $2 349.30
(0.49%) $27.67
(0.99%) $931.25
(-0.18%) $0.933
(-0.32%) $10.99
(-0.31%) $0.798
(1.14%) $92.92
Live Chart Being Loaded With Signals
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally...
Stats | |
---|---|
Dagens volum | 2.40M |
Gjennomsnittsvolum | 22.53M |
Markedsverdi | 16.37M |
EPS | £0 ( 2023-09-11 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.510 |
ATR14 | £0.0140 (2.72%) |
Volum Korrelasjon
Yourgene Health PLC Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Yourgene Health PLC Korrelasjon - Valuta/Råvare
Yourgene Health PLC Økonomi
Annual | 2022 |
Omsetning: | £37.56M |
Bruttogevinst: | £21.37M (56.88 %) |
EPS: | £-0.00260 |
FY | 2022 |
Omsetning: | £37.56M |
Bruttogevinst: | £21.37M (56.88 %) |
EPS: | £-0.00260 |
FY | 2021 |
Omsetning: | £18.29M |
Bruttogevinst: | £11.38M (62.20 %) |
EPS: | £-0.0307 |
FY | 2020 |
Omsetning: | £16.61M |
Bruttogevinst: | £10.22M (61.55 %) |
EPS: | £-0.00400 |
Financial Reports:
No articles found.
Yourgene Health PLC
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.